Approximately 43.3 percent of respondents believed that the vaccine against COVID-19 would be overall efficient. However, 24.4 percent of respondents considered that the vaccine would be efficient only to a very small extent.
To what extent do you consider that the vaccine against COVID-19 will be efficient?*
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Poll on vaccination decision against COVID-19 in Romania 2021
- Basic Statistic Cumulative number of coronavirus (COVID-19) vaccinations in Finland 2022
- Basic Statistic Reasons for refusing the vaccine against COVID-19 in Romania 2022
- Basic Statistic Romanians' opinion on the differences between the Pfizer and the Moderna vaccine 2021
- Basic Statistic Main characteristics of the vaccination campaign against COVID-19 in Romania 2021
- Premium Statistic Projected decline in hepatitis C complications in the U.S. by 2050
- Basic Statistic Prevalence of chronic health conditions among Canadian First Nations youth 2015-2016
- Premium Statistic Chronic health condition prevalence among Canadian First Nations children 2015-2016
- Basic Statistic Daily number of COVID-19 vaccination doses in Eswatini 2023
- Basic Statistic Daily number of COVID-19 vaccination doses in Namibia 2023
About the region
10
- Basic Statistic Key figures on COVID-19 vaccination in Romania 2023
- Basic Statistic Daily COVID-19 vaccinations in Romania 2020-2022
- Basic Statistic Number of COVID-19 vaccines received by Romania 2022, by type
- Basic Statistic Prices for antibody test after COVID-19 vaccine in Romania 2021, by clinic
- Premium Statistic Romania: dressings packaged for medical use export value 2012-2022
- Premium Statistic Workout frequency during the emergency regime in Romania 2020, by type of sports
- Premium Statistic Most sold medicine in Romania during the COVID-19 pandemic 2020
- Premium Statistic Romania: main reasons for receiving a vaccination in 2019
- Premium Statistic Romania: reasons for not receiving a vaccination in the last five years as of 2019
- Premium Statistic Romania: opinion on the importance of vaccines to provide protection in 2019
Other regions
10
- Basic Statistic Public opinion on vaccination in Poland 2019-2020
- Basic Statistic Specialist medical practitioners in Austria 2006-2016
- Premium Statistic Vaccinated one-year-old children in Colombia 2016-2021, by vaccine
- Basic Statistic Specialist medical practitioners in the Netherlands 2006-2015
- Basic Statistic Specialist medical practitioners in France 2006-2016
- Basic Statistic Specialist medical practitioners in Finland 2006-2015
- Basic Statistic Specialist medical practitioners in Switzerland 2008-2016
- Basic Statistic Specialist medical practitioners in the Czech Republic 2008-2013
- Basic Statistic Specialist medical practitioners in Belgium 2006-2015
- Basic Statistic Treatment for illicit drug use among Canadian First Nations Adults as of 2015-2016
Related statistics
3
Further related statistics
10
- GSK's operating profit by division 2006-2021
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Doctor visits in Germany - number per capita 1991-2021
- Leading European medtech countries based on market capitalization 2014
Further Content: You might find this interesting as well
Statistics
- GSK's operating profit by division 2006-2021
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Doctor visits in Germany - number per capita 1991-2021
- Leading European medtech countries based on market capitalization 2014
Europa FM. (December 30, 2020). To what extent do you consider that the vaccine against COVID-19 will be efficient?* [Graph]. In Statista. Retrieved May 13, 2024, from https://www.statista.com/statistics/1195158/romania-efficiency-of-the-vaccine-against-covid-19/
Europa FM. "To what extent do you consider that the vaccine against COVID-19 will be efficient?*." Chart. December 30, 2020. Statista. Accessed May 13, 2024. https://www.statista.com/statistics/1195158/romania-efficiency-of-the-vaccine-against-covid-19/
Europa FM. (2020). To what extent do you consider that the vaccine against COVID-19 will be efficient?*. Statista. Statista Inc.. Accessed: May 13, 2024. https://www.statista.com/statistics/1195158/romania-efficiency-of-the-vaccine-against-covid-19/
Europa FM. "To What Extent Do You Consider That The Vaccine against Covid-19 Will Be Efficient?*." Statista, Statista Inc., 30 Dec 2020, https://www.statista.com/statistics/1195158/romania-efficiency-of-the-vaccine-against-covid-19/
Europa FM, To what extent do you consider that the vaccine against COVID-19 will be efficient?* Statista, https://www.statista.com/statistics/1195158/romania-efficiency-of-the-vaccine-against-covid-19/ (last visited May 13, 2024)
To what extent do you consider that the vaccine against COVID-19 will be efficient?* [Graph], Europa FM, December 30, 2020. [Online]. Available: https://www.statista.com/statistics/1195158/romania-efficiency-of-the-vaccine-against-covid-19/